The search for revolutionary medicines has largely been hampered by the lack of biological models to predict clinical response. With the advent of technological advances that allow us to chemically probe biological complexity, the ability to identify and validate targets that significantly modulate disease biology is being realized. This symposium is aimed at highlighting ground-breaking chemical biology approaches to dissect disease processes and impact drug discovery. Register
The 7th Yao Yuan Biotech-Pharma Symposium
At the Interface of Chemistry & Biology for Drug Discovery
Time: April 18, 2015
Venue: University of Illinois at Chicago, College of Pharmacy Auditorium
Chuan He, John T. Wilson Distinguished Service Professor and Director of Institute for Biophysical Dynamics, The University of Chicago; Investigator of Howard Hughes Medical Institute (HHMI)
Neil L. Kelleher, Walter and Mary Elizabeth Glass Professor, Northwestern University
Mark Murcko, Former CTO of Vertex, Co-inventor of Three Marketed Drugs (Agenerase, Lexiva, Incivek) and Many Drug Candidates
Andrew Myers, Amory Houghton Professor of Chem & Chem Biol, Harvard University
Ed Reilly, Sr. Research Fellow & Project Director, AbbVie, Inc.
Student Poster Award and Presentations
Panel Discussion: What Skills and Experience Are Pharma Looking For?
Dr. Scott E. Warder (Sr. Scientist III, Target Enabling Sci. & Tech., AbbVie, Inc. )
Dr. Alexander Mankin (Professor and Director, Center for Pharmaceutical Biotechnology, College of Pharmacy, University of Illinois at Chicago)
Click here For Registration